75 related articles for article (PubMed ID: 24134957)
21. Expression patterns of the steroid receptor coactivator family in human ovarian endometriosis.
Kumagami A; Ito A; Yoshida-Komiya H; Fujimori K; Sato A
J Obstet Gynaecol Res; 2011 Oct; 37(10):1269-76. PubMed ID: 21518137
[TBL] [Abstract][Full Text] [Related]
22. Identification of markers of possible prognostic value in 57 giant cell tumors of bone.
Gamberi G; Serra M; Ragazzini P; Magagnoli G; Pazzaglia L; Ponticelli F; Ferrari C; Zanasi M; Bertoni F; Picci P; Benassi MS
Oncol Rep; 2003; 10(2):351-6. PubMed ID: 12579271
[TBL] [Abstract][Full Text] [Related]
23. Imbalanced expression pattern of steroid receptor coactivator-1 and -3 in liver cancer compared with normal liver: An immunohistochemical study with tissue microarray.
Li S; Zhang H; Yu Y; Liu M; Guo D; Zhang X; Zhang J
Oncol Lett; 2018 Nov; 16(5):6339-6348. PubMed ID: 30405769
[TBL] [Abstract][Full Text] [Related]
24. Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment.
Han SJ; Sung N; Wang J; O'Malley BW; Lonard DM
Breast Cancer Res; 2022 Oct; 24(1):73. PubMed ID: 36316775
[TBL] [Abstract][Full Text] [Related]
25. Localization and sex-difference of steroid receptor coactivator-1 immunoreactivities in the brain of adult female and male mice.
Bian C; Zhang D; Guo Q; Cai W; Zhang J
Steroids; 2011 Feb; 76(3):269-79. PubMed ID: 21145336
[TBL] [Abstract][Full Text] [Related]
26. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway.
Yan J; Yu CT; Ozen M; Ittmann M; Tsai SY; Tsai MJ
Cancer Res; 2006 Nov; 66(22):11039-46. PubMed ID: 17108143
[TBL] [Abstract][Full Text] [Related]
27. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.
Cheng S; Liu W; Mercado M; Ezzat S; Asa SL
Endocr Relat Cancer; 2009 Jun; 16(2):455-66. PubMed ID: 19261683
[TBL] [Abstract][Full Text] [Related]
28. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
[TBL] [Abstract][Full Text] [Related]
29. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
30. Expression of steroid receptor coactivators in cultured cells from paired myometrial and fibroid tissues.
Hussein-Fikret S; Fuller PJ; Gargett CE
J Soc Gynecol Investig; 2005 Sep; 12(6):445-51. PubMed ID: 15979354
[TBL] [Abstract][Full Text] [Related]
31. Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients.
Ibrahim T; Sacanna E; Gaudio M; Mercatali L; Scarpi E; Zoli W; Serra P; Ricci R; Serra L; Kang Y; Amadori D
Clin Breast Cancer; 2011 Dec; 11(6):369-75. PubMed ID: 21764390
[TBL] [Abstract][Full Text] [Related]
32. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
[TBL] [Abstract][Full Text] [Related]
33. [Expression and amplification of steroid receptor coactivator-3 gene in colorectal carcinoma and its clinicopathological significance].
Zeng SD; Xie D; Lin F; Wang CX; Tao Y; Zhang M
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jan; 8(1):67-70. PubMed ID: 16149006
[TBL] [Abstract][Full Text] [Related]
34. Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.
Liu H; Fan Q; Zhang Z; Li X; Yu H; Meng F
Hum Pathol; 2008 Feb; 39(2):167-74. PubMed ID: 18045647
[TBL] [Abstract][Full Text] [Related]
35. Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer.
Asioli S; Maletta F; Verdun di Cantogno L; Satolli MA; Schena M; Pecchioni C; Botta C; Chiusa L; Molinaro L; Conti L; Viale G; Ingravallo G; Maiorano E; Sapino A
Hum Pathol; 2012 Nov; 43(11):2070-9. PubMed ID: 22658277
[TBL] [Abstract][Full Text] [Related]
36. Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.
Minner S; Jessen B; Stiedenroth L; Burandt E; Köllermann J; Mirlacher M; Erbersdobler A; Eichelberg C; Fisch M; Brümmendorf TH; Bokemeyer C; Simon R; Steuber T; Graefen M; Huland H; Sauter G; Schlomm T
Clin Cancer Res; 2010 Mar; 16(5):1553-60. PubMed ID: 20179235
[TBL] [Abstract][Full Text] [Related]
37. Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1.
McBryan J; Theissen SM; Byrne C; Hughes E; Cocchiglia S; Sande S; O'Hara J; Tibbitts P; Hill AD; Young LS
Cancer Res; 2012 Jan; 72(2):548-59. PubMed ID: 22108824
[TBL] [Abstract][Full Text] [Related]
38. Regional specific regulation of steroid receptor coactivator-1 immunoreactivity by orchidectomy in the brain of adult male mice.
Bian C; Zhang K; Zhao Y; Guo Q; Cai W; Zhang J
Steroids; 2014 Oct; 88():7-14. PubMed ID: 24945110
[TBL] [Abstract][Full Text] [Related]
39. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers.
Waltregny D; Bellahcène A; de Leval X; Florkin B; Weidle U; Castronovo V
J Bone Miner Res; 2000 May; 15(5):834-43. PubMed ID: 10804012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
